Diffuse large B-cell lymphoma (DLBCL) most commonly appears as a fast-growing, painless lump, typically in the neck, armpit, or groin. It can also show up as a mass deep in the abdomen, as skin nodules, or as bright spots on a PET scan. What it “looks like” depends on where it develops and how it’s being examined.
Swollen Lymph Nodes
The most recognizable sign of DLBCL is a swollen lymph node you can feel under the skin. These lumps tend to be firm, rubbery, and painless. Unlike the tender, pea-sized nodes that swell during a cold or infection, lymphoma nodes keep growing over weeks rather than shrinking on their own. They can appear in the neck, armpit, or groin, and some people notice a rapidly enlarging mass in the abdomen instead.
Speed of growth is a distinguishing feature. DLBCL is classified as an aggressive lymphoma, meaning the mass can double in size within weeks. A node that was barely noticeable a month ago may become clearly visible or start pressing on nearby structures. That rapid timeline often prompts people to seek medical attention.
What It Looks Like on the Skin
When DLBCL starts in or spreads to the skin, it produces visible changes that differ from typical rashes or moles. There are two main patterns.
Primary cutaneous DLBCL of the leg type appears as firm nodules or tumor-like bumps, usually on one or both lower legs. These bumps can look red or blue, with the exact shade varying depending on skin tone. They tend to grow steadily and may ulcerate over time.
A rarer form, intravascular DLBCL, looks different. It can show up as a hard patch of skin, a subtle bump, or an area resembling spider veins. The affected skin may appear purple or discolored and feel unusually firm to the touch. This type tends to develop on the torso or thighs and is often aggressive.
Whole-Body Symptoms
Beyond the visible lump, DLBCL can cause a set of systemic symptoms that doctors refer to as “B symptoms.” These include drenching night sweats that soak through clothing or sheets, unexplained fevers, and significant weight loss, defined as losing more than 10% of your body weight within six months without trying. Not everyone with DLBCL develops these symptoms, but when present, they typically signal more advanced or aggressive disease.
Other general signs include persistent fatigue, loss of appetite, and sometimes itching that has no obvious skin cause. If the lymphoma is pressing on structures inside the chest or abdomen, you might notice shortness of breath, abdominal fullness, or a feeling of pressure.
What It Looks Like Under a Microscope
When a doctor biopsies a suspicious lump, a pathologist examines the tissue to confirm whether it’s DLBCL. Under the microscope, the hallmark is sheets of abnormally large immune cells (B lymphocytes) that have lost their normal architecture. These cells are medium to large, with nuclei at least twice the size of a normal lymphocyte’s nucleus. Instead of being organized into the tidy clusters you’d see in a healthy lymph node, they spread in a diffuse pattern that wipes out the node’s usual structure.
To confirm the diagnosis, pathologists stain the tissue for a protein called CD20, which sits on the surface of B cells. Additional markers like CD10, BCL2, BCL6, and MYC help classify the lymphoma into subtypes, which matters for treatment planning. One important distinction is whether the cancer cells resemble normal germinal center B cells (the GCB subtype) or activated B cells (the ABC subtype), as this affects prognosis.
What It Looks Like on Imaging
PET-CT scans are the primary imaging tool for DLBCL, and the results are often dramatic. DLBCL tumors are highly metabolically active, meaning they consume glucose at a much faster rate than surrounding tissue. On a PET scan, this shows up as intensely bright “hot spots” against the darker background of normal organs.
Doctors quantify that brightness using a measurement called SUVmax. In a study published in the Journal of Nuclear Medicine, patients with DLBCL had a median SUVmax of about 24, with values ranging from roughly 6 to over 60. For context, normal tissue usually registers around 2 to 3. Values below 10 are considered relatively low for DLBCL, while very high values can signal more aggressive disease. These scans reveal not just the primary tumor but also any additional sites of involvement throughout the body, making them essential for staging.
When It Develops Outside Lymph Nodes
Up to 40% of DLBCL cases begin in locations other than lymph nodes, a pattern called extranodal disease. The stomach and intestines are common sites, where the lymphoma may appear as a thickened area of the digestive wall, sometimes causing pain, nausea, or bleeding. On endoscopy, it can look like an ulcer or a mass protruding into the digestive tract.
DLBCL can also develop in the brain, bones, testes, or virtually any organ. In the brain, it typically appears on MRI as a mass that enhances brightly with contrast dye, often located deep within the brain tissue. In bone, it may cause pain and show up as a destructive lesion on X-ray or CT. The appearance in each location mimics other conditions common to that organ, which is why biopsy remains the only definitive way to confirm the diagnosis.